Van Roy F - Search Results

1

Hormone sensitivity in vitro and in vivo of v-ras-transfected MCF-7 cell derivatives.

Van Roy F, Mareel M, Vleminckx K, Beyaert R, Fiers W, Devleeschouwer N, Muquardt C, Legros N, Bracke M, Leclercq G. Van Roy F, et al. Int J Cancer. 1990 Sep 15;46(3):522-32. doi: 10.1002/ijc.2910460332. Int J Cancer. 1990. PMID: 2203690

2

Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice.

Mareel MM, Behrens J, Birchmeier W, De Bruyne GK, Vleminckx K, Hoogewijs A, Fiers WC, Van Roy FM. Mareel MM, et al. Among authors: van roy fm. Int J Cancer. 1991 Apr 1;47(6):922-8. doi: 10.1002/ijc.2910470623. Int J Cancer. 1991. PMID: 2010235

3

The invasive phenotypes.

Mareel MM, Van Roy FM, De Baetselier P. Mareel MM, et al. Among authors: van roy fm. Cancer Metastasis Rev. 1990 Jul;9(1):45-62. doi: 10.1007/BF00047588. Cancer Metastasis Rev. 1990. PMID: 2208568 Review.

4

Micro-encapsulation of MDCK-ras-e cells prevents loss of E-cadherin invasion-suppressor function in vivo.

Vandenbossche GM, De Bruyne GK, Bruyneel EA, Clemminck G, Vleminckx K, Van Roy FM, Mareel MM. Vandenbossche GM, et al. Among authors: van roy fm. Int J Cancer. 1994 Apr 1;57(1):73-80. doi: 10.1002/ijc.2910570114. Int J Cancer. 1994. PMID: 7512077

5

Enlarged cell-associated proteoglycans abolish E-cadherin functionality in invasive tumor cells.

Vleminckx KL, Deman JJ, Bruyneel EA, Vandenbossche GM, Keirsebilck AA, Mareel MM, van Roy FM. Vleminckx KL, et al. Among authors: van roy fm. Cancer Res. 1994 Feb 15;54(4):873-7. Cancer Res. 1994. PMID: 8313373

6

Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro.

Bracke ME, Vyncke BM, Bruyneel EA, Vermeulen SJ, De Bruyne GK, Van Larebeke NA, Vleminckx K, Van Roy FM, Mareel MM. Bracke ME, et al. Among authors: van roy fm, van larebeke na. Br J Cancer. 1993 Aug;68(2):282-9. doi: 10.1038/bjc.1993.329. Br J Cancer. 1993. PMID: 8347483 Free PMC article.

7

Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid.

Vermeulen SJ, Bruyneel EA, van Roy FM, Mareel MM, Bracke ME. Vermeulen SJ, et al. Among authors: van roy fm. Br J Cancer. 1995 Dec;72(6):1447-53. doi: 10.1038/bjc.1995.528. Br J Cancer. 1995. PMID: 8519658 Free PMC article.

8

Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line.

Vanhaesebroeck B, Van Bladel S, Lenaerts A, Suffys P, Beyaert R, Lucas R, Van Roy F, Fiers W. Vanhaesebroeck B, et al. Among authors: van bladel s, van roy f. Cancer Res. 1991 May 1;51(9):2469-77. Cancer Res. 1991. PMID: 1849793

9

Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo.

Vanhaesebroeck B, Mareel M, Van Roy F, Grooten J, Fiers W. Vanhaesebroeck B, et al. Among authors: van roy f. Cancer Res. 1991 Apr 15;51(8):2229-38. Cancer Res. 1991. PMID: 2009541

10

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F. Vleminckx K, et al. Among authors: van roy f. Cell. 1991 Jul 12;66(1):107-19. doi: 10.1016/0092-8674(91)90143-m. Cell. 1991. PMID: 2070412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters